Only a small number of your patients that are diagnosed with pancreatic cancer will be able to have surgery, in this session we explored three ablative therapies as alternative treatment options. We outlined radiotherapy (including SABR), IRE and Oncosil, who may be suitable for them, the advantages and disadvantages of each and what your patients may expect, so you can better support your patients and their families.

View the agenda

  • 10.00 – 10.10: Welcome and introductions
  • 10.10 – 10.35: Radiotherapy (including SABR) – Ganesh Radhakrishna, Consultant Clinical Oncologist, The Christie Hospital
  • 10.35 – 11.00: IRE – Nicola de Liguori-Carino, Consultant Hepatobiliary and Pancreatic Surgeon, Manchester Royal Infirmary
  • 11.00 – 11.25: Oncosil – Ajith Thankamma, Consultant Clinical Oncologist, Cambridge University Hospitals NHS Foundation Trust
  • 11.25 – 11.30: Close

Watch the session

Recording: Non-surgical treatment options: Ablative therapies, 26th October 2022, 10 - 11.30

If you have any questions, please don’t hesitate to get in touch with us at